Your session is about to expire
← Back to Search
Orthopedic Surgery
Surgical vs Non-Surgical Treatment for Hip Fracture
N/A
Recruiting
Led By Mai P. Nguyen, MD
Research Sponsored by HealthPartners Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2, 2 weeks, 6 weeks, and 3 months after treatment
Awards & highlights
Study Summary
This trial compares different treatments for elderly patients with pelvic ring fractures, to see which is better for pain & mobility. No current evidence-based guidelines exist.
Who is the study for?
This trial is for people aged 60 or older with a specific type of pelvic fracture (LC1) caused by low energy events like falls. They must have significant pain or difficulty moving even with help, and the injury should be recent, within four weeks. It's not for those with certain implants, unstable fractures, neurological issues, dementia, cancer-related fractures, non-walkers before the injury, other studies' participants or if they can't follow up.Check my eligibility
What is being tested?
The study compares two treatments for elderly patients with LC1 pelvic fractures: one group receives percutaneous transiliac-transsacral screw fixation (a minimally invasive surgical procedure), while the other gets standard care including pain management and physical therapy without surgery.See study design
What are the potential side effects?
Potential side effects from the surgical intervention may include infection risk at the incision site, bleeding complications during or after surgery, nerve damage leading to numbness or weakness in legs and possible need for additional surgeries if initial fixation fails.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks, 6 weeks, and 3 months after treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks, 6 weeks, and 3 months after treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Discharge Disposition Location
Hospital Length of Stay
Longest Distance of Ambulation
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: OperativeExperimental Treatment1 Intervention
Percutaneous transiliac-transsacral screw fixation
Group II: Non-operativeExperimental Treatment1 Intervention
Pain management and physical therapy advanced with weight bearing as tolerated.
Find a Location
Who is running the clinical trial?
Orthopaedic Trauma AssociationOTHER
32 Previous Clinical Trials
4,916 Total Patients Enrolled
HealthPartners InstituteLead Sponsor
186 Previous Clinical Trials
3,716,067 Total Patients Enrolled
Allina Health SystemOTHER
56 Previous Clinical Trials
1,175,114 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had an injury in the last 4 weeks.I experience significant pain or can't move well, even with help, after a mobility test.I have been diagnosed with dementia.My pelvis injury is severe and affects stability.I have a broken bone because of my cancer.I cannot have sacral fixation due to an implant or my sacral bone shape.I am 60 years old or older.My pelvic fracture is confirmed by X-ray, CT, or MRI.I was unable to walk before my injury.My fracture occurred due to a low energy event or for no clear reason.I have a condition or injury that stops me from walking.I am experiencing sudden symptoms affecting my brain or nerves.I have injuries that affect my ability to walk.
Research Study Groups:
This trial has the following groups:- Group 1: Operative
- Group 2: Non-operative
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this experiment accommodate people aged sixty and above?
"This trial requires applicants to be aged between 60 and 100. In contrast, there are 69 studies for those under 18 years old and 313 trials available for seniors over the age of 65."
Answered by AI
Who would be the ideal candidates for this research initiative?
"This medical trial has limited eligibility criteria; applicants must be aged between 60 and 100 years old, with a lateral compression 1 pelvic fracture. To fill the quota of 100 participants, recruitment is in progress."
Answered by AI
Are there any available openings in this medical research study?
"Confirmed by the clinicaltrials.gov platform, this research is not recruiting at present. The trial was published on March 1st 2023 and last modified 8 days later; however, there are currently 371 other trials that are actively enrolling."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger